MedPage Today on MSN
Next-Gen Nerve Stimulator Approved for Obstructive Sleep Apnea
Device will not carry concentric collapse contraindication or warning language ...
LivaNova (Nasdaq:LIVN) announced today that it received FDA premarket approval (PMA) for its aura6000 neuromodulation system ...
LivaNova has announced that the U.S. Food & Drug Administration (FDA) has granted premarket approval (PMA) for the aura6000 System for the treatment of adult patients with moderate to severe obstructi ...
Patients with COPD and coexisting OSAS have greater impairments in muscle quality and physical performance than those with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results